Toma de decisión sobre tecnologías sanitarias en COVID-19

Hasdeu, Santiago; Beliera, Anabel; Sánchez Viamonte, Julián.
Ciudad Autónoma de Buenos Aires; Ministerio de Salud de la Nación. Dirección de Investigación en Salud; 2021. 1 p.
No convencional en Español | ARGMSAL, BINACIS | ID: biblio-1428840

Documentos relacionados

  1. Evaluating the effectiveness of drug and therapeutics committees (DTCs) in controlling irrational drug use: A retrospective analysis.
  2. Establishment of a children's Drugs and Therapeutics Committee to ensure evidence-based and cost-effective medical treatment for children.
  3. La commission médicale d'établissement.
  4. "There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence.
  5. Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees.
  6. Global formulary review: how do we integrate pharmacogenomic information?
  7. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
  8. Applying principles of formulary management to blood banking.
  9. Cost-effectiveness of drug therapy prescribed in special situations at hospital.
  10. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.